M B Khazaeli - JoVE Visualize

Showing results (41-50 of 104) with videos related to

Pageof 11

Sort By:

Journal of Cancer Research and Clinical Oncology|January 1, 1994

Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitroM E Marshall, K Kervin, C Benefield, et al.

Human Antibodies and Hybridomas|October 1, 1993

An animal model to predict the immunogenicity of murine V regions in humansA M Cartner, R M Conry, A Safavy, et al.

Journal of the National Cancer Institute|August 17, 1988

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.

American Journal of Obstetrics and Gynecology|January 1, 1987

Radioimmunoscintigraphic detection of occult gestational choriocarcinomaR L Wahl, M B Khazaeli, A F LoBuglio, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002

Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapySui Shen, Ruby F Meredith, Jun Duan, et al.

Endocrinology|October 1, 1981

Development and characterization of a monoclonal antibody which distinguishes the beta-subunit of human chorionic gonadotropin (beta hCG) in the presence of the hCGM B Khazaeli, B G England, R C Dieterle, et al.

Bioorganic & Medicinal Chemistry|January 13, 2000

Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA)L L Chappell, B E Rogers, M B Khazaeli, et al.

The Journal of Urology|June 1, 1987

Development and characterization of a monoclonal antibody to human embryonal carcinomaM B Khazaeli, W H Beierwaltes, G S Pitt, et al.

Journal of the National Cancer Institute|August 17, 1988

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.

Pharmaceutical Research|June 1, 1990

Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.

Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:

Pageof 11

Journal of Cancer Research and Clinical Oncology|January 1, 1994

Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitroM E Marshall, K Kervin, C Benefield, et al.

Human Antibodies and Hybridomas|October 1, 1993

An animal model to predict the immunogenicity of murine V regions in humansA M Cartner, R M Conry, A Safavy, et al.

Journal of the National Cancer Institute|August 17, 1988

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.

American Journal of Obstetrics and Gynecology|January 1, 1987

Radioimmunoscintigraphic detection of occult gestational choriocarcinomaR L Wahl, M B Khazaeli, A F LoBuglio, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002

Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapySui Shen, Ruby F Meredith, Jun Duan, et al.

Endocrinology|October 1, 1981

Development and characterization of a monoclonal antibody which distinguishes the beta-subunit of human chorionic gonadotropin (beta hCG) in the presence of the hCGM B Khazaeli, B G England, R C Dieterle, et al.

Bioorganic & Medicinal Chemistry|January 13, 2000

Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA)L L Chappell, B E Rogers, M B Khazaeli, et al.

The Journal of Urology|June 1, 1987

Development and characterization of a monoclonal antibody to human embryonal carcinomaM B Khazaeli, W H Beierwaltes, G S Pitt, et al.

Journal of the National Cancer Institute|August 17, 1988

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.

Pharmaceutical Research|June 1, 1990

Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.

Pageof 11